GC
AMPH icon

Guggenheim Capital’s Amphastar Pharmaceuticals AMPH Stock Holding History

Guggenheim Capital’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-6,184
Closed -$247K – 1866
2024
Q2 		$247K Buy
6,184
+1,573
+34% +$65.2K ﹤0.01% 1705
2024
Q1 		$202K Buy
4,611
+133
+3% +$6.87K ﹤0.01% 1793
2023
Q4 		$277K Sell
4,478
-1,571
-26% -$82.5K ﹤0.01% 1704
2023
Q3 		$278K Sell
6,049
-78
-1% -$4.25K ﹤0.01% 1651
2023
Q2 		$352K Sell
6,127
-5,739
-48% -$254K ﹤0.01% 1609
2023
Q1 		$445K Sell
11,866
-6,303
-35% -$207K ﹤0.01% 1536
2022
Q4 		$509K Buy
18,169
+4,096
+29% +$119K ﹤0.01% 1479
2022
Q3 		$395K Sell
14,073
-1,171
-8% -$38.2K ﹤0.01% 1568
2022
Q2 		$531K Sell
15,244
-15,911
-51% -$568K ﹤0.01% 1557
2022
Q1 		$1.12M Sell
31,155
-3,036
-9% -$86.1K 0.01% 1306
2021
Q4 		$796K Sell
34,191
-2,865
-8% -$58.6K ﹤0.01% 1472
2021
Q3 		$704K Buy
+37,056
New +$726K ﹤0.01% 1596
2017
Q2 		– Sell
-12,003
Closed -$173K – 2831
2017
Q1 		$173K Sell
12,003
-62,715
-84% -$986K ﹤0.01% 2645
2016
Q4 		$1.38M Sell
74,718
-62,497
-46% -$1.22M ﹤0.01% 1946
2016
Q3 		$2.6M Buy
137,215
+58,349
+74% +$1.06M 0.01% 1442
2016
Q2 		$1.27M Sell
78,866
-18,799
-19% -$265K ﹤0.01% 1872
2016
Q1 		$1.17M Buy
97,665
+4,995
+5% +$58.9K ﹤0.01% 1954
2015
Q4 		$1.32M Sell
92,670
-16,971
-15% -$224K ﹤0.01% 1932
2015
Q3 		$1.28M Sell
109,641
-4,899
-4% -$73.5K ﹤0.01% 1948
2015
Q2 		$2.01M Buy
+114,540
New +$1.79M 0.01% 1765

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Guggenheim Capital's AMPH Position: Q3 2024 in Review

Guggenheim Capital sold out of Amphastar Pharmaceuticals (AMPH) in Q3 2024, closing a stake of 6,184 shares — an estimated $247K sold.

Guggenheim Capital first reported a position in AMPH in Q2 2015 and held it in 20 quarters. The position peaked at $2.6M in Q3 2016. 279 funds tracked by Wall St. Rank hold AMPH as of Q3 2024.

  • Guggenheim Capital reported no remaining Amphastar Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Guggenheim Capital sold 6,184 Amphastar Pharmaceuticals shares in Q3 2024, an estimated $247K.
  • Guggenheim Capital first reported a position in Amphastar Pharmaceuticals in Q2 2015 and held it in 20 quarters.
  • Guggenheim Capital's Amphastar Pharmaceuticals position peaked at $2.6M in Q3 2016.
  • 279 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2024.

Based on Guggenheim Capital's 13F filing for Q3 2024, filed 13 Nov 2024.